← HAEMONETICS CORP HAE
Market Price
$90.81
Market Cap
$4.11B
P/E Ratio
44.30
Revenue (FY 2026)
↓-2.0% YoY
$1.33B
3-Yr CAGR: 4.5%
Net Income
↓-42.0% YoY
$97.31M
Net Margin: 7.3%
Free Cash Flow
↑82.8% YoY
$260.44M
FCF Yield: 6.34%
EPS (Diluted)
↓-38.1% YoY
$2.05
Basic: $2.06
Return on Equity
Efficiency
12.2%
ROA: 147.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (HAE)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $886.1M | — | $378.5M | $-26.3M | — | $-0.51 | — | $159.7M | $83.6M | — |
| FY 2018 | $903.9M | +2.0% | $411.9M | $45.6M | +273.5% | $0.85 | +266.7% | $220.3M | $145.6M | +74.1% |
| FY 2019 | $967.6M | +7.0% | $417.5M | $55.0M | +20.7% | $1.04 | +22.4% | $159.3M | $40.3M | -72.3% |
| FY 2020 | $988.5M | +2.2% | $484.5M | $76.5M | +39.1% | $1.48 | +42.3% | $158.2M | $109.5M | +171.5% |
| FY 2021 | $870.5M | -11.9% | $397.8M | $79.5M | +3.8% | $1.55 | +4.7% | $108.8M | $71.8M | -34.4% |
| FY 2022 | $993.2M | +14.1% | $505.5M | $43.4M | -45.4% | $0.84 | -45.8% | $172.3M | $75.8M | +5.6% |
| FY 2023 | $1,168.7M | +17.7% | $615.1M | $115.4M | +166.1% | $2.24 | +166.7% | $273.1M | $162.9M | +115.0% |
| FY 2024 | $1,309.1M | +12.0% | $691.5M | $117.6M | +1.9% | $2.29 | +2.2% | $181.8M | $115.5M | -29.1% |
| FY 2025 | $1,360.8M | +4.0% | $749.0M | $167.7M | +42.6% | $3.31 | +44.5% | $181.7M | $142.4M | +23.4% |
| FY 2026 | $1,334.0M | -2.0% | $787.6M | $97.3M | -42.0% | $2.05 | -38.1% | $293.2M | $260.4M | +82.8% |
Valuation
Market Price
$90.81
Market Cap
$4.11B
Enterprise Value
$5.09B
P/E Ratio
44.30
P/B Ratio
5.18
FCF Yield
6.34%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
59.04%
Operating Margin
11.75%
Net Margin
7.29%
Return on Equity (ROE)
12.22%
Return on Assets (ROA)
146.96%
Asset Turnover
20.15x
Revenue 3-Yr CAGR
4.51%
Financial Health & Liquidity
Current Ratio
0.23
Cash Ratio
0.87
Debt / Equity
1.538
Debt / Assets
18.494
Cash & Equivalents
$245.44M
Total Debt
$1.22B
Book Value / Share
$17.52
Cash Flow Efficiency
Operating Cash Flow
$293.22M
Capital Expenditures (CapEx)
$32.78M
Free Cash Flow
$260.44M
OCF / Revenue
21.98%
FCF / Revenue
19.52%
FCF 3-Yr CAGR
16.94%
Per Share Metrics
EPS (Diluted)
$2.05
EPS (Basic)
$2.06
Dividends / Share
N/A
Book Value / Share
$17.52
EPS YoY Growth
-38.07%
Balance Sheet (FY 2026)
Total Assets
$66.21M
Total Liabilities
$282.60M
Stockholders' Equity
$796.32M
Current Assets
$66.21M
Current Liabilities
$282.60M